Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar DoomTrader (20.20) Submitted: 8/2/2012 4:01:54 PM : Underperform Start Price: $82.54 AMGN Score: +1.57

Overvalued

Report this Post Reply

Featured Broker Partners


Advertisement